WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) saw an uptick in trading volume on Wednesday . Approximately 111,093 shares traded hands during mid-day trading, an increase of 52% from the previous session’s volume of 72,933 shares.The stock last traded at $10.20 and had previously closed at $9.90.
WuXi Biologics (Cayman) Trading Down 0.5%
The firm has a fifty day moving average of $8.91 and a 200 day moving average of $9.10.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Further Reading
- Five stocks we like better than WuXi Biologics (Cayman)
- AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
- 3 Stocks That Prove the AI Trade Isn’t Over, It Moved
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
